A patient is anxious about what his therapist truly thinks about him. Does the patient have a right to review the therapist’s ...

New BPEI preclinical data address treatment protocol, corneal biochemical environment, fungal resistance mechanism, MRSA ...

New BPEI preclinical data address treatment protocol, corneal biochemical environment, fungal resistance mechanism, MRSA biofilm inhibition, and ...

Conference Call and Webcast Today at 8:30 a.m. ETPositive 12-month data from the OCU410 Phase 2 ArMaDa clinical trial for geographic atrophy (GA) ...

The clinical environment of 2026 requires more than just textbook knowledge; it demands a seamless integration of systematic physical assessment skills with modern AI-driven learning aids. With the ...

Over the past few years, specialty care has seen a surge in artificial intelligence (AI) tools designed to reduce ...

When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...

Artiva Biotherapeutics (ARTV) is maintained as a "Buy," driven by FDA alignment for a single phase 3 trial of AlloNK plus ...

Empirical research on AI and mental health is burgeoning. Some studies are using waitlist controls. Here's what you need to ...

Initial CX-801 clinical data in advanced melanoma, both as monotherapy and in combination with KEYTRUDA, are expected by the end of 2026, with observed tolerability at doses surpassing the approved ...

Good morning, and welcome to Ocugen First Quarter 2026 Financial Results and Business Update. [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate ...